vs
Side-by-side financial comparison of Nano Labs Ltd (NA) and Instil Bio, Inc. (TIL). Click either name above to swap in a different company.
Nano Labs Ltd is the larger business by last-quarter revenue ($2.7M vs $2.2M, roughly 1.2× Instil Bio, Inc.). Nano Labs Ltd runs the higher net margin — 754.5% vs -365.3%, a 1119.8% gap on every dollar of revenue.
Weebit Nano is a public semiconductor IP company founded in Israel in 2015 and headquartered in Hod HaSharon, Israel. The company develops Resistive Random-Access Memory technologies. Resistive Random-Access Memory is a specialized form of non-volatile memory (NVM) for the semiconductor industry. The company's products are targeted at a broad range of NVM markets where persistence, performance, and endurance are all required. ReRAM technology can be integrated in electronic devices like weara...
Instil Bio Inc. is a clinical-stage biotechnology company focused on developing innovative tumor-infiltrating lymphocyte (TIL) therapies for patients with difficult-to-treat advanced solid tumors. It operates in the immuno-oncology segment, serving patient populations that show limited response to existing standard cancer treatment options.
NA vs TIL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.7M | $2.2M |
| Net Profit | $20.3M | $-8.2M |
| Gross Margin | — | — |
| Operating Margin | — | -426.3% |
| Net Margin | 754.5% | -365.3% |
| Revenue YoY | — | -19.2% |
| Net Profit YoY | — | 31.1% |
| EPS (diluted) | $1.03 | $-1.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.7M | $2.2M | ||
| Q3 25 | — | $2.2M | ||
| Q2 25 | $1.2M | $2.2M | ||
| Q1 25 | — | $2.2M | ||
| Q4 24 | — | $2.8M | ||
| Q3 24 | — | $1.5M | ||
| Q2 24 | $3.5M | $0 | ||
| Q1 24 | — | $0 |
| Q4 25 | $20.3M | $-8.2M | ||
| Q3 25 | — | $-13.6M | ||
| Q2 25 | $-985.5K | $-21.4M | ||
| Q1 25 | — | $-28.2M | ||
| Q4 24 | — | $-11.9M | ||
| Q3 24 | — | $-23.0M | ||
| Q2 24 | $-8.0M | $-14.9M | ||
| Q1 24 | — | $-24.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | — | — |
| Q4 25 | — | -426.3% | ||
| Q3 25 | — | -670.0% | ||
| Q2 25 | -459.2% | -1045.5% | ||
| Q1 25 | — | -1363.2% | ||
| Q4 24 | — | -426.1% | ||
| Q3 24 | — | -1582.8% | ||
| Q2 24 | -237.2% | — | ||
| Q1 24 | — | — |
| Q4 25 | 754.5% | -365.3% | ||
| Q3 25 | — | -606.0% | ||
| Q2 25 | -85.2% | -954.2% | ||
| Q1 25 | — | -1257.8% | ||
| Q4 24 | — | -428.8% | ||
| Q3 24 | — | -1541.9% | ||
| Q2 24 | -231.3% | — | ||
| Q1 24 | — | — |
| Q4 25 | $1.03 | $-1.13 | ||
| Q3 25 | — | $-2.01 | ||
| Q2 25 | $-0.06 | $-3.24 | ||
| Q1 25 | — | $-4.32 | ||
| Q4 24 | — | $-1.82 | ||
| Q3 24 | — | $-3.54 | ||
| Q2 24 | $-0.12 | $-2.29 | ||
| Q1 24 | — | $-3.74 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.9M | $6.6M |
| Total DebtLower is stronger | $24.5M | — |
| Stockholders' EquityBook value | $106.5M | $113.9M |
| Total Assets | $159.3M | $203.5M |
| Debt / EquityLower = less leverage | 0.23× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.9M | $6.6M | ||
| Q3 25 | — | $5.8M | ||
| Q2 25 | $50.8M | $7.7M | ||
| Q1 25 | — | $15.4M | ||
| Q4 24 | — | $8.8M | ||
| Q3 24 | — | $6.7M | ||
| Q2 24 | $3.3M | $6.8M | ||
| Q1 24 | — | $5.5M |
| Q4 25 | $24.5M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $24.8M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $22.5M | — | ||
| Q1 24 | — | — |
| Q4 25 | $106.5M | $113.9M | ||
| Q3 25 | — | $120.4M | ||
| Q2 25 | $86.8M | $131.7M | ||
| Q1 25 | — | $144.9M | ||
| Q4 24 | — | $169.4M | ||
| Q3 24 | — | $176.3M | ||
| Q2 24 | $-5.1M | $195.0M | ||
| Q1 24 | — | $205.8M |
| Q4 25 | $159.3M | $203.5M | ||
| Q3 25 | — | $211.8M | ||
| Q2 25 | $206.4M | $231.0M | ||
| Q1 25 | — | $237.4M | ||
| Q4 24 | — | $263.6M | ||
| Q3 24 | — | $272.6M | ||
| Q2 24 | $51.2M | $294.3M | ||
| Q1 24 | — | $306.3M |
| Q4 25 | 0.23× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.29× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-8.3M | $-7.1M |
| Free Cash FlowOCF − Capex | $-8.4M | — |
| FCF MarginFCF / Revenue | -312.3% | — |
| Capex IntensityCapex / Revenue | 2.9% | — |
| Cash ConversionOCF / Net Profit | -0.41× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-8.3M | $-7.1M | ||
| Q3 25 | — | $-10.6M | ||
| Q2 25 | $-7.1M | $-14.8M | ||
| Q1 25 | — | $-4.2M | ||
| Q4 24 | — | $-10.6M | ||
| Q3 24 | — | $-20.1M | ||
| Q2 24 | $-10.8M | $-10.6M | ||
| Q1 24 | — | $-14.4M |
| Q4 25 | $-8.4M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-7.2M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-15.4M | — | ||
| Q1 24 | — | — |
| Q4 25 | -312.3% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -620.3% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -443.4% | — | ||
| Q1 24 | — | — |
| Q4 25 | 2.9% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 7.2% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | 133.1% | — | ||
| Q1 24 | — | — |
| Q4 25 | -0.41× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
